Browse the evidence

Stimulating de novo adipogenesis (adipocyte hyperplasia) in visceral white adipose tissue during caloric excess drives healthy tissue remodeling, maintaining insulin sensitivity and preventing metabolic syndrome.

Focus on where your body stores fat and how it handles it, not just the scale. Visceral fat accumulation and inability to create new fat cells (hyperplasia) are key drivers of metabolic disease. While you cannot directly 'choose' where fat goes, maintaining metabolic health through exercise and diet supports healthy adipose function. Avoid extreme caloric deficits that may overwhelm adipose expandability, leading to ectopic fat storage in organs.

Fibro-inflammatory progenitors (FIPs) in adipose tissue are anti-adipogenic and promote inflammation and fibrosis, contributing to unhealthy adipose remodeling.

Chronic inflammation in fat tissue can be driven by specific cell types (FIPs) that block healthy fat storage. Managing inflammation through diet and exercise may help reduce the activity of these anti-adipogenic cells, allowing for healthier fat tissue expansion.

Administration of the intestine-restricted FXR agonist fexaramine (FEX) improves glucose tolerance and promotes adipose tissue browning in mice by reshaping gut microbiota to increase lithocholic acid (LCA) production, which activates TGR5/GLP-1 signaling.

This research suggests that specific bile acid signaling, influenced by gut bacteria, plays a key role in how your body handles sugar and fat storage. While this study used a specific drug (fexaramine) in mice, it highlights the importance of gut health in metabolic regulation. For now, there is no direct human supplement equivalent, but maintaining a diverse gut microbiome through diet is a logical step to support these natural pathways.

Higher fecal short-chain fatty acid (SCFA) levels are associated with gut dysbiosis, increased gut permeability, obesity, and cardiometabolic risk factors, suggesting that high fecal SCFA excretion reflects inefficient absorption rather than health benefits.

High levels of short-chain fatty acids in your stool might not be a sign of a healthy gut; this study links them to obesity and metabolic risks. This suggests your body might not be absorbing these beneficial compounds efficiently. Focus on overall gut health and diversity rather than just maximizing SCFA production, as poor absorption (high fecal SCFA) is a marker of metabolic dysregulation.

High-intensity interval exercise increases cerebral angiogenesis and VEGFA levels via the lactate receptor HCAR1, a mechanism absent in skeletal muscle.

To maximize brain blood vessel growth, you likely need to exercise at high intensities that elevate blood lactate levels, as this triggers a specific receptor (HCAR1) that low-intensity exercise may not sufficiently activate.

Sleep deprivation accelerates the progression of neurodegenerative diseases, particularly Alzheimer's, by impairing the glymphatic clearance of beta-amyloid (Aβ) and increasing neuroinflammation.

Prioritize 7-8 hours of sleep to support your brain's waste clearance system. Sleep deprivation impairs the glymphatic system, leading to the accumulation of beta-amyloid plaques associated with Alzheimer's disease. Consistent, adequate sleep is a critical protective factor for long-term cognitive health.

Population-wide restriction of dietary saturated fat intake below current levels does not reduce cardiovascular disease risk and may increase stroke risk, as evidenced by recent large-scale observational studies and meta-analyses of randomized trials.

Current evidence suggests that strictly limiting saturated fat intake for the general population does not lower heart disease risk and may even increase stroke risk. Focus on whole food sources of fat (like dairy and meat) within a balanced diet rather than aiming for a specific low-saturated-fat percentage, especially if you are replacing fats with refined carbohydrates.

Estrogen deficiency during menopause leads to dysregulated lipid metabolism, characterized by increased LDL-C, increased triglycerides, and altered HDL subfractions, thereby increasing cardiovascular disease risk.

Understand that the drop in estrogen after menopause naturally raises your LDL cholesterol and triglycerides while lowering protective HDL. This increases your risk of heart disease. Managing this through diet (healthy fats, fiber) and potentially medical intervention is crucial for long-term heart health.

Poor social engagement (including poor social network and poor social support) is associated with a significantly increased risk of developing dementia.

Prioritize building and maintaining a reliable social network and seeking social support, as these structural aspects of socialization are linked to a lower risk of dementia. Focus on objective measures like having a close friend, regular contact, and support systems rather than just subjective feelings of loneliness, which showed less consistent protective effects in this analysis.

Androgen excess drives metabolic dysfunction in PCOS by promoting visceral adiposity, inducing insulin resistance through adipocyte hypertrophy and reduced adiponectin, and suppressing brown adipose tissue thermogenesis.

For women with PCOS, metabolic issues like insulin resistance and visceral fat accumulation are strongly linked to high androgen levels, not just diet. Treating the hormonal imbalance (e.g., via anti-androgens or insulin-sensitizers) may be necessary to address metabolic health, as lifestyle changes alone may be insufficient if androgen excess persists.

Insulin resistance in PCOS is characterized by selective ovarian insulin resistance (hyper-sensitivity) alongside peripheral resistance, which exacerbates androgen production.

Standard insulin-sensitizing treatments (like metformin) can help lower androgens by reducing insulin levels, which in turn reduces the ovarian stimulation of androgen production.

Consumer wearable sleep trackers generally overestimate total sleep time and sleep efficiency while underestimating wake after sleep onset compared to polysomnography, with high sensitivity but low specificity for wake detection.

Use wearable sleep trackers to observe long-term trends in your sleep habits, not to diagnose sleep disorders. Expect them to overestimate how much you slept and underestimate how much you were awake. For clinical concerns, rely on professional sleep studies (PSG).

Lean NAFLD, defined as fatty liver in non-obese individuals, is a significant subset of NAFLD (7-20%) and is associated with insulin resistance and metabolic dysfunction despite normal BMI.

You do not need to be overweight to develop fatty liver. Lean NAFLD affects 7-20% of NAFLD cases and is linked to insulin resistance and metabolic issues. If you have fatty liver, focus on metabolic health markers like blood sugar and insulin sensitivity, not just your weight.

Acute exercise induces mitophagy in skeletal muscle via an AMPK-dependent phosphorylation of Ulk1 at Serine 555, which is required for targeting damaged mitochondria to lysosomes.

Regular exercise triggers a specific cellular cleanup process (mitophagy) that removes damaged mitochondria. This process is driven by the AMPK-Ulk1 signaling pathway. To ensure this cleanup happens, consistent aerobic exercise is required to activate AMPK, which then phosphorylates Ulk1 to target damaged organelles for degradation.

AMPK is required for exercise-induced mitophagy, as blocking AMPK activity abolishes the increase in mitophagic markers (pure red puncta) following exercise.

If your AMPK pathway is impaired (e.g., due to metabolic disease or specific genetic factors), your body may fail to perform the necessary cleanup of damaged mitochondria after exercise, potentially blunting long-term health benefits.

Ulk1 is required for the targeting of mitochondria to lysosomes during exercise-induced mitophagy, but is not required for lysosomal biogenesis itself.

Ulk1 acts as a specific tagger that directs damaged mitochondria to lysosomes for destruction. Without Ulk1, the cell may still produce more lysosomes, but it fails to effectively target and degrade the damaged mitochondria.

Obesity increases susceptibility to Covid-19 through mechanisms including chronic inflammation, immune dysfunction, altered lung mechanics, and increased ACE2 expression.

Obesity contributes to severe Covid-19 through chronic inflammation, immune issues, lung mechanics, and higher ACE2 expression. Weight management and medical care for obesity are important for reducing risk.

Diabetes increases susceptibility to Covid-19 through mechanisms including aggravated inflammatory storms, immune dysfunction, lung injury, and increased ACE2 expression.

Diabetes contributes to severe Covid-19 through chronic inflammation, immune issues, lung injury, and higher ACE2 expression. Good glycemic control and medical care for diabetes are important for reducing risk.

Amino acid availability, specifically leucine and arginine, regulates cellular protein synthesis and autophagy via the mTORC1 signaling pathway, where depletion inactivates mTORC1 to trigger autophagy and reduce protein biosynthesis.

To maximize muscle protein synthesis, ensure your diet provides sufficient leucine and arginine to activate the mTORC1 pathway. If these amino acids are depleted, your body shifts to breaking down its own proteins via autophagy. This means the quality and specific amino acid profile of your protein intake matter as much as the total amount.

Systemic amino acid homeostasis is maintained by exchanging essential amino acids for non-essential ones and transferring amino groups from oxidized amino acids to biosynthesis, minimizing net loss through oxidation.

Your body actively recycles amino acids. It swaps essential for non-essential ones and reuses nitrogen from broken-down proteins to make new ones. This minimizes the need to constantly eat protein, though essential amino acids must still be obtained from food.

CD36 fatty acid translocase drives hepatosteatosis onset and progression to NASH by increasing fatty acid influx into hepatocytes, making it a key driver of NAFLD pathogenesis.

Current research suggests that the protein CD36 plays a significant role in moving fatty acids into liver cells, contributing to fatty liver disease. While there is no specific diet protocol mentioned to target CD36 directly, the findings highlight that managing fatty acid influx is critical. Future treatments may target CD36, but for now, standard NAFLD management focusing on reducing metabolic stress is implied.

Saturated fatty acids (SFAs) are more hepatotoxic than unsaturated fatty acids (UFAs) because they induce ER stress, oxidative stress, and apoptosis more effectively.

Not all fats affect the liver equally. Saturated fats are more likely to cause liver damage and inflammation than unsaturated fats. Reducing saturated fat intake may help mitigate liver stress in NAFLD patients.

M1 macrophage/Kupffer cell polarization drives insulin resistance and NASH progression, while M2 polarization protects against it.

Liver inflammation in NAFLD is driven by immune cells (Kupffer cells) shifting into a pro-inflammatory 'M1' state. Shifting these cells to an 'M2' state is protective. While lifestyle changes help, specific micronutrients like carotenoids are being studied for their ability to force this M2 shift.

In Type 2 Diabetes (T2D), beta cell functional impairment is an early predictor of disease progression, often preceding significant loss of beta cell mass.

In T2D, restoring beta cell function (e.g., through weight loss or bariatric surgery) can reverse diabetes rapidly, often before any significant change in beta cell mass occurs. Focus on functional recovery.